News
9hon MSN
Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...
Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Eli Lilly LLY -1.05% ...
5don MSN
Eli Lilly ( LLY 0.90%) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following ...
Part of the appeal of amylin analogs is the potential to drive weight loss without causing the same level of tolerability problems as GLP-1 receptor agonists. Lilly reported relatively low rates of ...
Mounjaro has sold more than 81,570 units in India, totalling about ₹23.94 crore ($2.76 million) as of May, with the drug ...
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
Zacks Investment Research on MSN1d
What is the Intent Behind Eli Lilly's Recent M&A Deals Spree?Eli Lilly LLY signed a definitive agreement to acquire Verve Therapeutics VERV for a total deal value of nearly $1.3 billion.
Pharmaceutical Technology on MSN1d
Eli Lilly and Eisai’s Alzheimer’s drugs denied NHS use due to high costsNICE said it made every effort to support reimbursement for Kisunla and Leqembi, but found the medicines are “not good value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback